Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neos Therapeutics Inc. NEOS

Healthcare Drug Manufacturers - Major
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In... see more

Recent & Breaking News (NDAQ:NEOS)

Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote "FOR" the Pending Merger With Aytu BioScience

GlobeNewswire March 12, 2021

Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote "FOR" the Pending Merger With Aytu BioScience

GlobeNewswire March 10, 2021

Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021

GlobeNewswire February 10, 2021

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS

PR Newswire January 30, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Neos Therapeutics, Inc. - NEOS

PR Newswire January 28, 2021

Moore Kuehn Encourages MTSC, SPRQ, NEOS, and PRSP Investors to Contact Law Firm

GlobeNewswire January 28, 2021

Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference

GlobeNewswire January 4, 2021

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PS, BEAT, HCAP, NEOS, HBAN

PR Newswire December 28, 2020

Lifshitz Law Firm, P.C. Announces Investigation of AJRD, CATM, EXPC, GNBF, LNKB, NEOS, AYTU, QEP, FANG, RP, RNET, and VSAT

PR Newswire December 24, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - BEAT, SNCA, BBIO, TLRY, NEOS

PR Newswire December 19, 2020

NEOS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Neos Therapeutics, Inc. - NEOS

PR Newswire December 16, 2020

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - CPAH, MTSC, NEOS, ZAGG

GlobeNewswire December 12, 2020

NEOS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NEOS and Encourages Investors to Contact the Firm

GlobeNewswire December 11, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Neos Therapeutics, Inc. Merger

GlobeNewswire December 11, 2020

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.

PR Newswire December 10, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Neos Therapeutics, Inc. (Nasdaq - NEOS)

ACCESSWIRE IA December 10, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc.

PR Newswire December 10, 2020

Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - NEOS

Business Wire December 10, 2020

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company

GlobeNewswire December 10, 2020

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company

Accesswire December 10, 2020